English
Back
Download
Log in to access Online Inquiry
Back to the Top

T 1 News Halt!

$BridgeBio Pharma (BBIO.US)$ Reuters
28 mins ago
Attruby™ (Acoramidis), a Near Complete Ttr Stabilizer (≥90%), Approved by FDA to Reduce Cardiovascular Death and Cardiovascular-Related Hospitalization in Attr-Cm Patients
BridgeBio Pharma Inc - to Receive $500 Million Payment Under Royalty Agreement
BridgeBio Pharma Inc - Grants Bayer Rights to Commercialize Acoramidis in Europe
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
65K Views
Comment
Sign in to post a comment
    5255
    Followers
    23
    Following
    76K
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.